When the third Pinnacle hip implant trial began in early October, the jury might not have imagined the case would be as complex as it is. The stakes are...
Janssen Pharmaceuticals and its parent company, Johnson & Johnson (J&J), have been fighting several dozen lawsuits concerning their diabetes medication Invokana. One lawsuit includes a Texas man who suffered...
Johnson & Johnson’s baby powder has been on the market for more than 100 years. While the product was originally designed to treat diaper rash on babies, by 1913...
After its third loss in the same St. Louis courtroom, healthcare giant Johnson & Johnson (J&J) is trying to move baby powder lawsuits to a New Jersey court where...
While more than 7,000 Xarelto lawsuits have been consolidated in a multidistrict litigation (MDL) to the Eastern District of Louisiana, there are nearly 1,000 cases pending in a Philadelphia...
The fifth Risperdal case to go to trial was a game changer for Janssen Pharmaceuticals and its parent company, Johnson & Johnson (J&J). The companies previously escaped large payouts...
Last week’s $70 million baby powder verdict confirmed what thousands of women already learned firsthand: baby powder can cause ovarian cancer. A St. Louis jury listened to testimony explaining...
When Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals received FDA approval for their antipsychotic Risperdal in 1993, the companies anticipated the drug would be a blockbuster hit....
Deborah Giannecchini can finally breathe a sigh of relief. Her long battle to hold baby powder manufacturer Johnson & Johnson (J&J) responsible for causing her ovarian cancer finally met...
The long road to trial for Deborah Giannecchini is almost at an end. She fought numerous attempts from healthcare giant Johnson & Johnson (J&J) both before and during her...